TechConnect Innovation Program

Small Molecule Inhibitors of RNA-Binding Protein Musashi for Cancer Treatment

University of Kansas, KS, United States

TECHNOLOGY SUMMARY

The invention relates to small molecules modulating functions of the RNA-binding protein Musashi for cancer treatment.

Primary Application Area: Pharmaceuticals & Personal Care

Technology Development Status: Prototype

Technology Readiness Level: TRL 4

FIGURES OF MERIT

Value Proposition: Unique chemical compounds and thus strong patent strength.

SHOWCASE SUMMARY

Organization Type: Academic/Gov Lab

Showcase Booth #: 13M

Website: www.kuic.ku.edu

GOVT/EXTERNAL FUNDING SOURCES

Government Funding/Support to Date:

Primary Sources of Funding: Federal Grant, University

Looking for: Both Funding and Development Partners